This lecture provides an overview of the current use of pre-diagnosis, post-diagnosis and post-treatment biomarkers in prostate cancer care today. The attendee will gain a knowledge of how to incorporate these novel markers into practice and for whom they are appropriate.

Contact hours available until 10/16/19.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online CNE evaluation.
You will be able to print your CNE certificate at any time after you complete the evaluation.

Conferences Committee Disclosures:

Gina Powley, MSN, RN, ANP - Speakers bureau for Astellas
Susanne Quallich, PhD, ANP-BC, NP-C, CUNP, FAANP - Consultant – Coloplast
Valre Welch, MSN, CPNP - Hollister Clinical Advisory Board

Speakers Conflict of Interest Disclosure:

There are no disclosures to declare.

Commercial Support and Sponsorship:

No commercial support or sponsorship declared.

Accreditation Statement:

The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556.

Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:

After completing this activity, the learner will be able to utilize all currently available diagnostic tests to enhance the diagnosis and management of men with elevated PSA and with prostate cancer.

Leslie A. Deane MB.BS, MS, FRCSC, FACS

Associate Professor of Urology, Rush University Medical Center

Appearances